← Back to Search

COPD Care Transition Programs for Chronic Obstructive Pulmonary Disease (REVISITS Trial)

N/A
Recruiting
Led By Valerie Press
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 24 months post-intervention (aim 3)
Awards & highlights

REVISITS Trial Summary

This trial will study two methods of delivering COPD care transition programs to see which is most effective in decreasing acute care revisits.

Who is the study for?
This trial is for US hospital sites, not individuals. It's designed to compare the effectiveness of virtual versus in-person care transition programs for patients with Chronic Obstructive Pulmonary Disease (COPD).Check my eligibility
What is being tested?
The study tests two COPD care transition interventions: one delivered in person and the other virtually. Both are supported by mentoring, with some sites also using co-design methods to implement these programs.See study design
What are the potential side effects?
Since this trial focuses on implementation strategies at hospital sites rather than direct patient interventions, it does not specify side effects related to medications or treatments.

REVISITS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 24 months post-intervention (aim 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 24 months post-intervention (aim 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Delivery of overall care transition program: penetration
Sustainability of effectiveness: 30-day revisits
Sustainability of program delivery: penetration
Secondary outcome measures
Cost/savings evaluation
Delivery of care transition program individual interventions: penetration
Healthcare Utilization: 30-day acute care revisits (all cause)
+18 more

REVISITS Trial Design

4Treatment groups
Experimental Treatment
Group I: Virtual intervention delivery with virtual mentoring with co-designExperimental Treatment1 Intervention
The implemented interventions will be virtual and will include virtual mentoring and co-design support with our study partner, Onda Collective. The mentored implementation model (MIM) is an evidence-based strategy to promote the success and sustainability of hospital-based quality improvement (QI) initiatives. After completing the contextual assessments and pre-implementation planning in Aim 1, the investigators will collaborate with the SHM to harness their expertise with the MIM to implement the COPD Program over a one-year period during Aim 2 (implementation). Virtual Mentored Implementation involves implementing their assigned care transition program intervention delivery method using an innovative virtual mentored implementation approach using tele-conferencing technology (i.e., video-conferences) for two-way visualization of individuals in different locations for educational purposes. Monthly mentoring sessions will occur to maximize mentors' input.
Group II: Virtual intervention delivery with virtual mentoringExperimental Treatment1 Intervention
The implemented interventions will be virtual and will include virtual mentoring. The mentored implementation model (MIM) is an evidence-based strategy to promote the success and sustainability of hospital-based quality improvement (QI) initiatives. After completing the contextual assessments and pre-implementation planning in Aim 1, the investigators will collaborate with the SHM to harness their expertise with the MIM to implement the COPD Program over a one-year period during Aim 2 (implementation). Virtual Mentored Implementation involves implementing their assigned care transition program intervention delivery method using an innovative virtual mentored implementation approach using tele-conferencing technology (i.e., video-conferences) for two-way visualization of individuals in different locations for educational purposes. Monthly mentoring sessions will occur to maximize mentors' input.
Group III: In-person intervention delivery with virtual mentoring and co-designExperimental Treatment1 Intervention
The implemented interventions will be in-person and will include virtual mentoring and co-design support with our study partner, Onda Collective. The mentored implementation model (MIM) is an evidence-based strategy to promote the success and sustainability of hospital-based quality improvement (QI) initiatives. After completing the contextual assessments and pre-implementation planning in Aim 1, the investigators will collaborate with the SHM to harness their expertise with the MIM to implement the COPD Program over a one-year period during Aim 2 (implementation). Virtual Mentored Implementation involves implementing their assigned care transition program intervention delivery method using an innovative virtual mentored implementation approach using tele-conferencing technology (i.e., video-conferences) for two-way visualization of individuals in different locations for educational purposes. Monthly mentoring sessions will occur to maximize mentors' input.
Group IV: In-person intervention delivery with virtual mentoringExperimental Treatment1 Intervention
The implemented interventions will be in-person and will include virtual mentoring. The mentored implementation model (MIM) is an evidence-based strategy to promote the success and sustainability of hospital-based quality improvement (QI) initiatives. After completing the contextual assessments and pre-implementation planning in Aim 1, the investigators will collaborate with the SHM to harness their expertise with the MIM to implement the COPD Program over a one-year period during Aim 2 (implementation). Virtual Mentored Implementation involves implementing their assigned care transition program intervention delivery method using an innovative virtual mentored implementation approach using tele-conferencing technology (i.e., video-conferences) for two-way visualization of individuals in different locations for educational purposes. Monthly mentoring sessions will occur to maximize mentors' input.

Find a Location

Who is running the clinical trial?

The Hospital Medicine Reengineering Network (HOMERuN)UNKNOWN
Onda CollectiveUNKNOWN
COPD FoundationOTHER
17 Previous Clinical Trials
238,290 Total Patients Enrolled

Media Library

COPD Transitions of Care Intervention Bundle: In-Person Interventions Clinical Trial Eligibility Overview. Trial Name: NCT05568043 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: In-person intervention delivery with virtual mentoring, In-person intervention delivery with virtual mentoring and co-design, Virtual intervention delivery with virtual mentoring, Virtual intervention delivery with virtual mentoring with co-design
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: COPD Transitions of Care Intervention Bundle: In-Person Interventions Highlights & Side Effects. Trial Name: NCT05568043 — N/A
COPD Transitions of Care Intervention Bundle: In-Person Interventions 2023 Treatment Timeline for Medical Study. Trial Name: NCT05568043 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still room for participants in this scientific research?

"Per the information on clinicaltrials.gov, enlistment for this research project is still in progress. This trial was initially listed on February 1st 2023 and has been updated most recently on April 5th 2023."

Answered by AI

To what extent is this clinical trial involving participants?

"Affirmative. Information on clinicaltrials.gov indicates that this medical research is actively enrolling volunteers, with the first posting being February 1st 2023 and the most recent update occurring April 5th 2023. The trial requires 24 participants from a single site of study."

Answered by AI

What should we expect the results of this trial to be?

"The primary focus of this clinical trial is to assess the sustainability of effectiveness at 12 months following enrollment in Aim 2. Secondary aims include evaluating Healthcare Utilization with 30-day acute care revisits for COPD, gauging Delivery of Care Transition Program Individual Interventions penetration and Cost/Savings Evaluation through hospital-level program costs and savings calculation."

Answered by AI

Who else is applying?

What site did they apply to?
University of Chicago
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
The Reducing REVISITS Study: A Cluster RCT
2022. "The Reducing REVISITS Study: A Cluster RCT". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05568043.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top